| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |